The Discounted Cash Flow (DCF) valuation of Exagen Inc (XGN) is (20.79) USD. With the latest stock price at 5.74 USD, the upside of Exagen Inc based on DCF is -462.2%.
Based on the latest price of 5.74 USD and our DCF valuation, Exagen Inc (XGN) is a sell. selling XGN stocks now will result in a potential gain of 462.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 8.6% | 7.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (88.85) - (12.46) | (20.79) |
| Upside | -1648.0% - -317.0% | -462.2% |